Advances in fluorescence imaging techniques to detect oral cancer and its precursors

Future Oncology

Volumn 6, Issue 7, 2010, Pages 1143-1154

  Shin, Dongsuk ^a   Vigneswaran, Nadarajah ^b   Gillenwater, Ann ^b   Richards Kortum, Rebecca ^a  

^a Rice University   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

diagnosis; image processing; optical fluorescence imaging; oral cancer

Indexed keywords

AUTOFLUORESCENCE; DIGITAL IMAGING; EARLY DIAGNOSIS; FLUORESCENCE IMAGING; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INFLAMMATION; MOUTH CANCER; PRECANCER; PRIORITY JOURNAL; REVIEW; DIAGNOSTIC IMAGING; FLUORESCENCE; MOUTH NEOPLASMS; PATHOLOGY; PRECANCEROUS CONDITIONS;

DIAGNOSTIC IMAGING; FLUORESCENCE; HUMANS; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS;

EID: 77954677828     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.10.79     Document Type: Review

References (62)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global Cancer Statistics, 2002. CA Cancer J. Clin. 55, 74-108 (2005).
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer Statistics, 2009. CA Cancer J. Clin. 59, 225-249 (2009).
3. Garcia M, Jemal A, Ward EM, et al.: Global Cancer Facts & Figures 2007. American Cancer Society, GA, USA (2007).
4. Peterson PE: The World Oral Health Report 2003: continuous improvement of oral health in the 21st Century - the approach of the WHO Global Oral Health Programme. Community Dent. Oral Epidemiol. 31(Suppl. 1), 3-24 (2003).
5. Petersen PE: Oral cancer prevention and control - the approach of the World Health Organization. Oral Oncol. 45, 454-460 (2009).
6. Scott SE, Grunfeld EA, McGurk M: The idiosyncratic relationship between diagnostic delay and stage of oral squamous cell carcinoma. Oral Oncol. 41(4), 396-403 (2005).
7. Evans SJ, Langdon JD, Rapidis AD, Johnson NW: Prognostic significance of STNMP and velocity of tumor growth in oral cancer. Cancer 49(4), 773-776 (1982).
8. Mashberg A, Samit AM: Early detection, diagnosis, and management of oral and oropharyngeal cancer. CA Cancer J. Clin. 39(2), 67-88 (1989).
9. Spiro RH: Squamous cancer of the tongue. CA Cancer J. Clin. 35(4), 252-256 (1985).
10. Dolan RW, Vaughan CW, Fuleihan N: Symptoms in early head and neck cancer: an inadequate indicator. Otolaryngol. Head Neck Surg. 119(5), 463-467 (1998).
11. Vernham GA, Crowther JA: Head and neck carcinoma - stage at presentation. Clin. Otolaryngol. Allied Sci. 19(2), 120-124 (1994).
12. Day GL, Blot WJ: Second primary tumors in patients with oral cancer. Cancer 70(1), 14-19 (1992).
13. Epstein JB, Sciubba JJ, Banasek TE, Hay LJ: Failure to diagnose and delayed diagnosis of cancer: medicolegal issues. J. Am. Dent. Assoc. 140(12), 1494-1503 (2009).
14. Peacock ZS, Pogrel MA, Schmidt BL: Exploring the reasons for delay in treatment of oral cancer. J. Am. Dent. Assoc. 139(10), 1346-1352 (2008).
15. Yu T, Wood RE, Tenenbaum HC: Delays in diagnosis of head and neck cancers. J. Can. Dent. Assoc. 74(1), 61 (2008).
16. Allison P, Locker D, Feine JS: The role of diagnostic delays in the prognosis of oral cancer: a review of the literature. Oral Oncol. 34(3), 161-170 (1998). (Pubitemid 28267166)
17. Fortin A, Bairati I, Albert M, Moore L, Allard J, Couture C: Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 52(4), 929-936 (2002).
18. Downer MC, Moles DR, Palmer S, Speight PM: A systemic review of test performance in screening for oral cancer and precancer. Oral Oncol. 40, 264-273 (2004).
19. Patton LL, Epstein JB, Kerr AR: Adjunctive techniques for oral cancer examination and lesion diagnosis. J. Am. Dent. Assoc. 139, 896-905 (2008).
20. Epstein JB, Gorsky M, Lonky S, Silverman S Jr, Epstein JD, Bride M: The efficacy of oral lumenoscopy™ (ViziLite® ) in visualizing oral mucosal lesions. Spec. Care Dentist 26(4), 171-174 (2006).
21. Kerr AR, Sirois DA, Epstein JB: Clinical evaluation of chemiluminescent lighting: an adjunct for oral mucosal examinations. J. Clin. Dent. 17(3), 59-63 (2006).
22. Ram S, Siar CH: Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int. J. Oral Maxillofac. Surg. 34(5), 521-527 (2005).
23. Farah CS, McCullough MJ: A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite™) in the visualisation of oral mucosal white lesions. Oral Oncol. 43, 820-824 (2007).
24. Oh ES, Laskin DM: Efficacy of the ViziLite system in the identification of oral lesions. J. Oral Maxillofac. Surg. 65(3), 424-426 (2007).
25. De Veld DC, Witjes MJ, Sterenborg HJ, Roodenburg JL: The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. Oral Oncol. 41, 117-131 (2005).
26. Roblyer D, Richards-Kortum R, Sokolov K, et al.: Multispectral optical imaging device for in vivo detection of oral neoplasia. J. Biomed. Opt. 13(2), 024019 (2008).
27. Lane PM, Gilhuly T, Whitehead P, et al.: Simple device for the direct visualization of oral-cavity tissue fluorescence. J. Biomed. Opt. 11(2), 024006 (2006).
28. Poh CF, Ng SP, Williams PM, et al.: Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck 29(1), 71-76 (2007).
29. Kois JC, Truelove E: Detecting oral cancer: A new technique and case reports. Dent. Today 25(10), 94, 96-97 (2006).
30. Poh CF, Williams PM, Zhang L, Rosin MP: Heads up! - A call for dentists to screen for oral cancer. J. Can. Dent. Assoc. 72(5), 413-416 (2006).
31. Westra WH, Sidransky D: Fluorescence visualization in oral neoplasia: shedding light on an old problem. Clin. Cancer Res. 12(22), 6594-6597 (2006).
32. Laronde DM, Poh CF, Williams PM, et al.: A magic wand for the community dental office? Observations from the British Columbia Oral Cancer Prevention Program. J. Can. Dent. Assoc. 73(7), 607-609 (2007).
33. Rosin MP, Poh CF, Guillard M, Williams PM, Zhang L, MacAulay C: Visualization and other emerging technologies as change makers for oral cancer prevention. Ann. NY Acad. Sci. 1098, 167-183 (2007).
34. Williams PM, Poh CF, Hovan AJ, Ng S, Rosin MP: Evaluation of a suspicious oral mucosal lesion. J. Can. Dent. Assoc. 74(3), 275-280 (2008).
35. Rosin MP, Poh CF, Elwood JM, et al.: New hope for an oral cancer solution: together we can make a difference. J. Can. Dent. Assoc. 74(3), 261-266 (2008).
36. Paulis M: The influence of patient education by the dental hygienist: acceptance of the fluorescence oral cancer exam. J. Dent. Hygiene 83(3), 134-140 (2009).
37. Kalmar JR: Advances in the detection and diagnosis of oral precancerous and cancerous lesions. Oral Maxillofac. Surg. Clin. N. Am. 18, 465-482 (2006).
38. Kelloff GJ, Sullivan DC, Baker H, et al.: Workshop on imaging science development for cancer prevention and preemption. Cancer Biomark. 3, 1-33 (2007).
39. Lingen MW: Oral cancer screening aids: where is the science? Oral Surg. Oral Med. Oral Path. Oral Rad. Oral Endo. 103(2), 153-154 (2007).
40. Lingen MW, Kalmar JR, Karrison T, Speight PM: Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 44(1), 10-22 (2007).
41. Trullenque-Eriksson A, Muñoz-Corcuera M, Campo-Trapero J, Cano-Sánchez J, Bascones-Martínez A: Analysis of new diagnostic methods in suspicious lesions of the oral mucosa. Med. Oral Patol. Oral Cir. Bucal. 14(5), E210-E216 (2009).
42. Rhodus NL: Oral cancer and precancer: improving outcomes. Compend. Contin. Educ. Dent. 30(8), 486-488, 490-494, 496-498 (2009).
43. Fedele S: Diagnostic aids in the screening of oral cancer. Head Neck Oncol. 1(1), 5 (2009).
44. Balevi B: Evidence-based decision-making: should the general dentist adopt the use of the VELscope for routine screening for oral cancer? J. Can. Dent. Assoc. 73(7), 603-606 (2007).
45. Huber MA: Assessment of the VELscope as an adjunctive examination tool. Tex. Dent. J. 126(6), 528-535 (2009).
46. Mehrotra R, Singh M, Thomas S, et al.: A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. J. Am. Dent. Assoc. 141(2), 151-156 (2010).
47. Missmann M, Jank S, Laimer K, Gassner R: A reason for the use of toluidine blue staining in the presurgical management of patients with oral squamous cell carcinomas. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 102, 741-743 (2006).
48. Kerawala CJ, Beale V, Reed M, Martin IC: The role of vital tissue staining in the marginal control of oral squamous cell carcinoma. Int. J. Oral Maxillofac. Surg. 29, 32-35 (2000).
49. Poh CF, Zhang L, Anderson DW, et al.: Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin. Cancer Res. 12(22), 6716-6722 (2006).
50. Poh CF, MacAulay CE, Zhang L, Rosin MP: Tracing the "at-risk" oral mucosa field with autofluorescence: steps toward clinical impact. Cancer Prev. Res. 2(5), 401-404 (2009).
51. Roblyer D, Kurachi C, Stepanek V, et al.: Objective detection and delineation of oral neoplasia using autofluorescence imaging. Cancer Prev. Res. 2(5), 423-431 (2009).
52. Pavlova I, Williams M, El-Naggar A, Richards-Kortum R, Gillenwater A: Understanding the biological basis of autofluorescence imaging for oral cancer detection: high-resolution fluorescence microscopy in viable tissue. Clin. Cancer Res. 14(8), 2396-2404 (2008).
53. Pavlova I, Weber CR, Schwarz RA, et al.: Monte Carlo model to describe depth selective fluorescence spectra of epithelial tissue: applications for diagnosis of oral precancer. J. Biomed. Opt. 13(6), 064012 (2008).
54. Pavlova I, Weber CR, Schwarz RA, Williams MD, Gillenwater AM, Richards-Kortum R: Fluorescence spectroscopy of oral tissue: Monte Carlo modeling with site-specific tissue properties. J. Biomed. Opt. 14(1), 014009 (2009).
55. Dwyer PJ, DiMarzio CA, Rajadhyaksha M: Confocal q line-scanning microscope for imaging human tissues. Appl. Optics 46(10), 1843-1851 (2007).
56. Shin H-J, Pierce MC, Lee D, Ra H, Solgaard O, Richards-Kortum R: Fiber-optic confocal microscope using a MEMS scanner and miniature objective lens. Opt. Express. 15(15), 9113-9122 (2007).
57. Maitland KC, Gillenwater AM, Williams MD, El-Naggar AK, Descour MR, Richards-Kortum RR: In vivo imaging of oral neoplasia using a miniaturized fiber optic confocal reflectance microscope. Oral Oncol. 44(11), 1059-1066 (2008).
58. Thong PS, Olivo M, Kho K-W, et al.: Laser confocal endomicroscopy as a novel technique for fluorescence diagnostic imaging of the oral cavity. J. Biomed. Opt. 12(1), 014007 (2007).
59. Haxel BR, Goetz M, Kiesslich R, Gosepath J: Confocal endomicroscopy: a novel application for imaging of oral and oropharyngeal mucosa in human. Eur. Arch. Otorhinolaryngol. 267(3), 443-448 (2010).
60. Muldoon TJ, Pierce MC, Nida DL, Williams MD, Gillenwater A, Richards-Kortum R: Subcellular-resolution molecular imaging within living tissue by fiber microendoscopy. Opt. Express. 15(25), 16413-16423 (2007).
61. Carlson AL, Coghlan LG, Gillenwater AM, Richards-Kortum RR: Dual-mode reflectance and fluorescence near-video-rate confocal microscope for architectural, morphological and molecular imaging of tissue. J. Microsc. 228(1), 11-24 (2007).
62. Carlson AL, Gillenwater AM, Williams MD, El-Naggar AK, Richards-Kortum RR: Confocal microscopy and molecular-specific optical contrast agents for the detection of oral neoplasia. Tech. Canc. Res. Treat. 6(5), 361-374 (2007).